Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma
Max S. Topp,
Johannes Duell,
Ana Maria Abajo Guijarro,
Marielle Odin,
Tina Nielsen,
Anand Rajeswaran,
Michael Wenger,
Christelle Zundel,
Aleksandra Bogucka-Fedorczuk,
Tomasz Wrobel
Affiliations
Max S. Topp
Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
Johannes Duell
Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
Ana Maria Abajo Guijarro
F. Hoffmann-La Roche Ltd, Basel, Switzerland
Marielle Odin
F. Hoffmann-La Roche Ltd, Basel, Switzerland
Tina Nielsen
F. Hoffmann-La Roche Ltd, Basel, Switzerland
Anand Rajeswaran
F. Hoffmann-La Roche Ltd, Basel, Switzerland
Michael Wenger
F. Hoffmann-La Roche Ltd, Basel, Switzerland
Christelle Zundel
F. Hoffmann-La Roche Ltd, Basel, Switzerland
Aleksandra Bogucka-Fedorczuk
Department of Hematology, Wrocław Medical University, Wrocław, Poland
Tomasz Wrobel
Department of Hematology, Wrocław Medical University, Wrocław, Poland
